论文信息 - Circulating miR-30b and miR-30c predict erlotinib response in EGFR-mutated non-small cell lung cancer patients. - 字舞流文

Circulating miR-30b and miR-30c predict erlotinib response in EGFR-mutated non-small cell lung cancer patients.

P. Meldgaard | J. Hojbjerg | Anne Winther-Larsen | B. Sørensen | M. Clement | E. B. F. Ebert